![DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor]()
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptorZhou, H.; Luo, Y.; Lo, J.-f.; Kaplan, C. D.; Mizutani, M.; Mizutani, N.; Lee, J.-D.; Primus, F. J.; Becker, J. C.; Xiang, R.; Reisfeld, R. A. · Proceedings of the National Academy of Sciences · 2005